Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance (Journal article)

Moutsopoulos, H. M./ Giotaki, H./ Maddison, P. J./ Mavridis, A. C./ Drosos, A. A./ Skopouli, F. N.

One hundred and twenty-four sera from Greek patients with autoimmune rheumatic diseases (29 with systemic lupus erythematosus (SLE), 24 with scleroderma, 11 with primary Sjogren's syndrome (SS), and 60 with rheumatoid arthritis (RA) were tested for antibodies to nRNP, Sm, Scl-70, Ro(SSA), and La(SSB) cellular antigens. The incidence of these antibodies in the different groups of patients examined, did not differ overall from that described previously. It was noted, however, that antibodies to Sm were very infrequently found in Greek patients with SLE and anti-Ro positive patients with SLE did not have the clinical manifestations described by other workers. Finally, it was found that anti-Ro positive patients with RA experienced a high frequency of side effects from penicillamine-D. The significance of these findings is discussed.
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antigens/*immunology,Arthritis, Rheumatoid/drug therapy/immunology,Autoantibodies/*analysis,*Autoantigens,Autoimmune Diseases/*immunology,Female,Greece,Humans,Lupus Erythematosus, Systemic/immunology,Male,Middle Aged,Penicillamine/adverse effects,*RNA, Small Cytoplasmic,Rheumatic Diseases/*immunology,*Ribonucleoproteins,Scleroderma, Systemic/immunology,Sjogren's Syndrome/immunology
ISSN: 0003-4967
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Moutsopoulos-1984-Antibodies to cellul.pdf442.93 kBAdobe PDFView/Open    Request a copy

 Please use this identifier to cite or link to this item:
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.